ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 84 filers reported holding ALLOVIR INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $0 | -100.0% | 467 | -93.7% | 0.00% | – |
| Q1 2024 | $6 | +20.0% | 7,467 | 0.0% | 0.00% | – |
| Q4 2023 | $5 | -93.2% | 7,467 | -78.3% | 0.00% | – |
| Q3 2023 | $74 | -5.1% | 34,388 | +50.6% | 0.00% | – |
| Q2 2023 | $78 | +169.0% | 22,830 | +213.9% | 0.00% | – |
| Q1 2023 | $29 | -73.6% | 7,274 | -66.1% | 0.00% | – |
| Q4 2022 | $110 | -99.9% | 21,474 | +63.0% | 0.00% | – |
| Q3 2022 | $104,000 | +103.9% | 13,173 | +0.7% | 0.00% | – |
| Q2 2022 | $51,000 | -42.7% | 13,087 | -0.5% | 0.00% | – |
| Q1 2022 | $89,000 | -67.6% | 13,154 | -38.1% | 0.00% | – |
| Q4 2021 | $275,000 | -48.5% | 21,259 | -0.2% | 0.00% | -100.0% |
| Q3 2021 | $534,000 | +1.9% | 21,293 | -19.8% | 0.00% | 0.0% |
| Q2 2021 | $524,000 | +5.2% | 26,551 | +24.7% | 0.00% | 0.0% |
| Q1 2021 | $498,000 | -20.6% | 21,300 | +30.7% | 0.00% | 0.0% |
| Q4 2020 | $627,000 | +181.2% | 16,300 | +101.2% | 0.00% | – |
| Q3 2020 | $223,000 | – | 8,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,323,371 | $15,683,000 | 0.66% |
| GMT CAPITAL CORP | 1,138,070 | $7,682,000 | 0.48% |
| RA Capital Management | 1,440,525 | $9,724,000 | 0.21% |
| Redmile Group, LLC | 823,371 | $5,558,000 | 0.17% |
| Samsara BioCapital, LLC | 82,336 | $556,000 | 0.14% |
| Woodline Partners LP | 1,087,093 | $7,338,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 93,166 | $629,000 | 0.08% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,532 | $7,719,000 | 0.04% |
| Virtus ETF Advisers LLC | 10,463 | $71,000 | 0.03% |
| PDT Partners, LLC | 30,198 | $204,000 | 0.02% |